Bronchiectasis is a heterogeneous disease with multiple causes and a highly variable clinical presentation. Biomarkers and the identification of endotypes hold promise in guiding clinical care and therapy. This review examines the evidence for biomarkers.
Read the pick of the week | Submit your manuscript to the European Respiratory Review
Friday, 19 July 2024
ERR pick of the week
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment